Sectors & IndustriesConsumer DefensivePharmaceutical Retailers

Best Pharmaceutical Retailer Stocks to Buy Now (2023)

Top pharmaceutical retailer stocks in 2023 ranked by overall Zen Score. See the best pharmaceutical retailer stocks to buy now, according to analyst forecasts for the pharmaceutical retailers industry.

According to Zen Score, the 3 best drug store stocks to buy right now are:

Leafly Holdings (NASDAQ:LFLY) is the top pharmaceutical retailer stock with a Zen Score of 35, which is 11 points higher than the pharmaceutical retailer industry average of 24. It passed 11 out of 33 due diligence checks and has average fundamentals. Leafly Holdings has seen its stock lose -55.49% over the past year, overperforming other pharmaceutical retailer stocks by 1 percentage points.

Leafly Holdings has an average 1 year price target of $60.00, an upside of 834.58% from Leafly Holdings's current stock price of $6.42.

Leafly Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Leafly Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Petmed Express (NASDAQ:PETS) is the second best pharmaceutical retailer stock with a Zen Score of 34, which is 10 points higher than the pharmaceutical retailer industry average of 24. It passed 11 out of 38 due diligence checks and has average fundamentals. Petmed Express has seen its stock lose -48% over the past year, overperforming other pharmaceutical retailer stocks by 9 percentage points.

Petmed Express has an average 1 year price target of $18.50, an upside of 80.49% from Petmed Express's current stock price of $10.25.

Petmed Express stock has a consensus Hold recommendation according to Wall Street analysts. Of the 2 analysts covering Petmed Express, 50% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.

Walgreens Boots Alliance (NASDAQ:WBA) is the third best pharmaceutical retailer stock with a Zen Score of 32, which is 8 points higher than the pharmaceutical retailer industry average of 24. It passed 10 out of 38 due diligence checks and has average fundamentals. Walgreens Boots Alliance has seen its stock lose -29.51% over the past year, overperforming other pharmaceutical retailer stocks by 27 percentage points.

Walgreens Boots Alliance has an average 1 year price target of $32.40, an upside of 45.68% from Walgreens Boots Alliance's current stock price of $22.24.

Walgreens Boots Alliance stock has a consensus Hold recommendation according to Wall Street analysts. Of the 10 analysts covering Walgreens Boots Alliance, 0% have issued a Strong Buy rating, 10% have issued a Buy, 80% have issued a hold, while 0% have issued a Sell rating, and 10% have issued a Strong Sell.

Out of 2 pharmaceutical retailer stocks that have issued dividends in the past year, the 2 pharmaceutical retailer stocks with the highest dividend yields are:

Petmed Express (NASDAQ:PETS) has an annual dividend yield of 11.71%, which is 2 percentage points higher than the pharmaceutical retailer industry average of 10.17%. Petmed Express's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Petmed Express's dividend has shown consistent growth over the last 10 years.

Petmed Express's dividend payout ratio of -750% indicates that its high dividend yield might not be sustainable for the long-term.

Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 8.63%, which is -2 percentage points lower than the pharmaceutical retailer industry average of 10.17%. Walgreens Boots Alliance's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Walgreens Boots Alliance's dividend has shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of -50% indicates that its high dividend yield might not be sustainable for the long-term.

Pharmaceutical retailer stocks were up 2.89% in the last day, and down -0.42% over the last week. Walgreens Boots Alliance was the among the top gainers in the pharmaceutical retailers industry, gaining 6.41% yesterday.

Walgreens Boots Alliance shares are trading higher following a report suggesting the company is considering former Cigna executive Tim Wentworth for the CEO role.

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical retailer stocks right now are:

Leafly Holdings (NASDAQ:LFLY) is the most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Leafly Holdings has a valuation score of 57, which is 35 points higher than the pharmaceutical retailer industry average of 22. It passed 4 out of 7 valuation due diligence checks.

Leafly Holdings's stock has dropped -55.49% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 1 percentage points.

Bimi International Medical (NASDAQ:BIMI) is the second most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Bimi International Medical has a valuation score of 43, which is 21 points higher than the pharmaceutical retailer industry average of 22. It passed 3 out of 7 valuation due diligence checks.

Bimi International Medical's stock has dropped -45.67% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 11 percentage points.

Medavail Holdings (NASDAQ:MDVL) is the third most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Medavail Holdings has a valuation score of 29, which is 7 points higher than the pharmaceutical retailer industry average of 22. It passed 2 out of 7 valuation due diligence checks.

Medavail Holdings's stock has dropped -84.94% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -28 percentage points.